3 Under-the-Radar IPO Stocks to Buy Before They Double | Investor Place
Last month, Tempus AI received U.S. Food and Drug Administration clearance for “Tempus ECG-AF device that uses AI to help identify patients who …
Read the original at InvestorPlace ↗
- Topics
- Markets & InvestmentHealthcare
- Mentions
- FDAUnited States
- Tags
- AI Use Case
- Tracked via
- Google Alert “that uses AI to”